Siegfried Holding AG (SWX:SFZN)

Market Cap	4.08B
Revenue (ttm)	1.29B
Net Income (ttm)	160.06M
Shares Out	4.38M
EPS (ttm)	36.88
PE Ratio	25.27
Forward PE	23.86
Dividend	3.80 (0.41%)
Ex-Dividend Date	May 3, 2024

Volume	10,291
Average Volume	10,870
Open	924.00
Previous Close	932.00
Day's Range	906.00 - 924.00
52-Week Range	843.00 - 1,188.00
Beta	0.69
RSI	41.91
Earnings Date	Aug 21, 2025

About Siegfried Holding AG

Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. The company offers drug substances, including exclusive synthesis that manufactures custom APIs. It also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition,...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1873
• Employees: 3,886
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: SFZN

Financial Performance

In 2024, Siegfried Holding AG's revenue was 1.29 billion, an increase of 1.82% compared to the previous year's 1.27 billion. Earnings were 160.06 million, an increase of 41.93%.